Central nervous system (CNS) pathologies are a public health concern, with viral infections
one of their principal causes. These viruses are known as neurotropic pathogens …

While it is well known that 98–99% of the human genome does not encode proteins, but are
nevertheless transcriptionally active and give rise to a broad spectrum of noncoding RNAs …

Calcitriol and hydroxyderivatives of lumisterol and tachisterol are secosteroid hormones with
immunomodulatory and anti-inflammatory properties. Since the beginning of the COVID-19 …

Besides respiratory illness, SARS-CoV-2, the causative agent of COVID-19, leads to
neurological symptoms. The molecular mechanisms leading to neuropathology after SARS …

The post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection is a multisystemic condition characterized by the persistence or emergence of …

Three years after SARS-CoV-2 emerged as a global infectious threat, the virus has become
endemic. The neurological complications such as depression, anxiety, and other CNS …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the
respiratory distress condition known as COVID-19. This disease broadly affects several …

SARS-CoV-2 primarily infects the lungs via the ACE2 receptor but also other organs
including the kidneys, the gastrointestinal tract, the heart, and the skin. SARS-CoV-2 also …

Since the emergence of the SARS-CoV-2 virus in 2019, nearly 700 million COVID-19 cases
and 7 million deaths have been reported globally. Despite most individuals recovering …

Initially reported as pneumonia of unknown origin, COVID-19 is increasingly being
recognized for its impact on the nervous system, despite nervous system invasions being …